Skandinaviska Enskilda Banken (SEB)
AUPH icon

Skandinaviska Enskilda Banken (SEB)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$108K – 803
2023
Q4 		$108K Hold
12,000
– – ﹤0.01% 867
2023
Q3 		$93K Sell
12,000
-2,400
-17% -$23.5K ﹤0.01% 875
2023
Q2 		$139K Buy
+14,400
New +$149K ﹤0.01% 882
2020
Q3 		– Sell
-4,600
Closed -$75K – 1032
2020
Q2 		$75K Buy
+4,600
New +$73.6K ﹤0.01% 974

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AUPH Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 12,000 shares — an estimated $108K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AUPH in Q2 2020 and held it in 4 quarters. The position peaked at $139K in Q2 2023. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 12,000 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $108K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Aurinia Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Aurinia Pharmaceuticals position peaked at $139K in Q2 2023.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.